quinazolines has been researched along with Craniopharyngioma, Adamantinous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Deng, J; Guo, G; Liu, Y; Peng, X; Tong, A; Wang, Y; Xu, J; You, C; Zhou, L | 1 |
1 other study(ies) available for quinazolines and Craniopharyngioma, Adamantinous
Article | Year |
---|---|
Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Topics: Adolescent; Adult; Aged; Annexin A2; Antineoplastic Agents; Brain; Cell Movement; Cell Proliferation; Child; Child, Preschool; Cohort Studies; Craniopharyngioma; ErbB Receptors; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Oncogene Protein v-akt; Pituitary Neoplasms; Prognosis; Quinazolines; Signal Transduction; Tumor Cells, Cultured; Young Adult | 2017 |